Introduction
In enzyme-prodrug antitumor therapy, expression of a foreign protein in cancer cells activates a prodrug to a cytotoxic form. 1, 2 The rationale for this type of therapy is to increase the therapeutic index in cancer treatment. 3 Transfer of the herpes simplex virus type 1 thymidine kinase (HSV-TK) gene into tumor cells sensitizes them to the antiviral drug ganciclovir (GCV). [4] [5] [6] [7] Numerous studies have demonstrated excellent cell killing with GCV in HSV-TK-expressing tumor cells both in vitro and in vivo. 2, 5, [8] [9] [10] [11] The antitumor activity is the result of phosphorylation of GCV by HSV-TK to GCVMP. [12] [13] [14] [15] [16] Upon further phosphorylation by endogenous cellular kinases to its cytotoxic triphosphate form, GCVTP then competes with endogenous dGTP for incorporation into DNA. 14, [17] [18] [19] [20] [21] We have demonstrated previously that GCV incorporation into DNA is associated with a delayed S-phase hypothesized to lead to cell death. 9 Success of this approach in animal tumor models has led to clinical trials in a variety of tumor types. [22] [23] [24] [25] An important feature of this form of enzyme-prodrug therapy is that HSV-TK-expressing cells can cause GCVmediated cytotoxicity in tumor cells that do not express the transgene, a process known as the bystander effect.
10, [26] [27] [28] Bystander cytotoxicity is critical for the enzyme-prodrug gene therapy strategy because current techniques for gene transfer typically result in fewer than 10% of the cells expressing the transgene. 22 In HSV-TK/ GCV therapy, bystander cytotoxicity has been effective at killing cocultures of HSV-TK-expressing and HSV-TKnon-expressing cells in vitro and at reducing tumor size in vivo.
10,11,29-36 HSV-TK expression in as few as 10% of tumor cells in vivo resulted in tumor regression or a significant reduction in tumor growth when GCV was administered. Bystander cytotoxicity has been attributed to the transfer of phosphorylated GCV metabolites from HSV-TK-expressing cells to non-HSV-TK-expressing bystander cells, presumably via protein channels known as gap junctions. 8, 29, [37] [38] [39] Gap junctions are composed of a hexameric arrangement of connexin protein, known as a connexon, on the surface of cells. When connexons from neighboring cells dock together, they form a central pore, which allows for the transfer of ions, metabolites, and messenger molecules p1 kDa in molecular weight.
We have demonstrated previously that cells with low gap junction intercellular communication (GJIC) can exhibit good bystander cytotoxicity both in vitro and in vivo. 8, 11, 44 These studies presented here further examine the role of GJIC in bystander cytotoxicity using two approaches. First, U251 glioblastoma cells, which exhibit high GJIC (480% communication between neighboring cells), were transfected with a dominant-negative connexin 43 (DNCx43) cDNA vector and the effect on bystander cytotoxicity was evaluated. 45 The DNCx43 cDNA has a 21 bp deletion corresponding to residues 130-136 of the intracellular loop. The presence of a single DNCx43 in a connexon allows it to dock with a connexon from an adjacent cell, but transport of metabolites between cells is inhibited. Second, bystander cell killing was studied in HeLa cells because they have been reported to be devoid of connexin protein, and therefore lack GJIC. 30, 33 In addition, a double dye flow cytometry technique was utilized to measure GJIC during the 24-h period of GCV incubation used in the bystander cytotoxicity experiment compared to the brief 10 min evaluation period used for Lucifer Yellow microinjection. [46] [47] [48] The results demonstrated that, although Lucifer Yellow microinjection suggested there was no GJIC in U251 cells expressing the DNCx43 and in HeLa cells, GJIC was observed by the double dye flow cytometry method. Further studies investigated the role of low GJIC on GCV phosphate transfer and bystander cytotoxicity.
Results

Effect of GJIC on HSV-TK and bystander cytotoxicity
We have previously demonstrated that U251 glioblastoma cells that express HSV-TK can induce multilog cell killing in cocultured bystander cells when incubated with GCV. 8, 9 Subsequent studies have demonstrated that bystander cytotoxicity was mediated by transfer of phosphorylated GCV from HSV-TK-expressing to HSV-TK-nonexpressing bystander cells, presumably through GJIC. 29 To examine the role of GJIC on bystander cytotoxicity and metabolite transfer, U251 cells were transfected with a DNCx43 cDNA vector. 45 Owing to a 21 bp deletion in the cDNA for DNCx43, Northern blot analysis of each of the DNCx43 clones demonstrated a lower molecular weight band compared to the endogenous wild-type Cx43 in rat liver epithelial cells (positive control) or empty vector-transfected cells (Figure 1a) . Similarly, by Western blot analysis, the DNCx43 clones exhibited a lower molecular weight band compared to the endogenous Cx43 (Figure 1b) . The multiple, slower migrating bands of the native Cx43 protein are due to different phosphorylation states. 47 Evaluation of GJIC by Lucifer Yellow microinjection demonstrated that GJIC was decreased in DNCx43-expressing cells (Table 1) . To determine the effect of decreased GJIC on bystander cytotoxicity, three cell lines were chosen for further study to represent a range of GJIC: clones DN7, DN10, and DN14, which exhibited 52.1, 30.4, and 0% GJIC, respectively. Each clonal cell line was cocultured with an equal number of HSV-TKexpressing U251 cells and cell survival was determined in a colony formation assay (Figure 2 ). For the combination of U251 HSV-TK-expressing and empty vector (control) bystander cells, only 50% of the cells in As predicted, cocultures with the DNCx43 bystander cells exhibited significantly less cell killing at all concentrations with 3 to 10-fold higher survival at concentrations of GCV X1 mM. However, there was still a substantial bystander effect since more than half of the coculture was killed. Interestingly, the cocultures containing any of the three dominant-negative clones exhibited a similar degree of cytotoxicity. Thus, expression of the DNCx43 cDNA reduced, but did not eliminate, bystander cytotoxicity. Furthermore, DNCx43 cDNA expression did not correlate with the degree of GJIC or the effect on GCV-mediated bystander cytotoxicity.
These results obtained with GJIC-deficient U251 cells were compared to HeLa cells, which are reportedly deficient in connexin protein expression and, thus, exhibit no GJIC (Table 1) . 30, 33 Stably transduced HeLa cells expressing HSV-TK or b-gal were cocultured with GCV, and bystander cytotoxicity was measured by survival of the b-gal-expressing cells. As illustrated in Figure 3 , no bystander cytotoxicity was observed in these cocultures with concentrations of GCV as high as 300 mM. 
Measurement of GJIC by double dye flow cytometry
The bystander killing in DNCx43-expressing U251 cells and the sparing of the HeLa HSV-TK-expressing cells when cocultured with bystander cells suggests that there was transfer of phosphorylated GCV between cells, despite the apparent lack of GJIC. Since Lucifer Yellow microinjection measured GJIC over the course of 5-10 min, while drug incubation to determine cytotoxicity was carried out over a 24 h time frame, a double dye flow cytometry technique was used to measure the ability of cells to transfer small molecules during the entire drug incubation period. One population of cells was stained with calcein, a soluble gap junction permeant, while the other population was stained with PKH26, a membranebound dye. The transfer of calcein to PKH26-stained cells, determined by flow cytometry, was used as a measure of GJIC ( Figure 5 ). 46, 48 Two separate populations appeared in the region of the flow diagram representing double dye fluorescence. The top right box represents a population with full calcein and full PKH26 fluorescence. The percentage of this population did not change over time (data not shown), and was decreased after correction for cell doublets. This region was concluded to represent cell aggregates. The top middle box represents a population with full PKH26 and variable calcein fluorescence. This population exhibited the characteristics of GJIC because transfer of calcein to PKH26-labeled cells occurred gradually with time, and only a portion of the calcein was transferred as expected for a gradient diffusion process (data not shown). The empty vector control cells had the highest level of calcein transfer of the cell lines studied with 84.0% of the cells exhibiting GJIC, similar to the levels determined by Lucifer Yellow microinjection ( Table 2 ). The DN14 clone exhibited 0% GJIC by Lucifer Yellow microinjection, but 29.0% of the cells demonstrated calcein uptake. HeLa cells, which reportedly have no connexin protein expression and, thus, should be incapable of GJIC, exhibited a small, but measurable, amount of calcein accumulation in approximately 22.6% of the PKH26-stained cells.
GCVTP levels in HeLa HSV-TK and bystander cells
With the results of double dye flow cytometry demonstrating transfer of a cytosolic dye between HeLa cell populations, we wished to determine whether or not phosphorylated GCV could be transferred. To accomplish this, fluorescence-activated cell sorting (FACS) was employed to separate cocultures of HeLa HSV-TKexpressing and PKH26-stained bystander cells after they had been incubated with GCV. Control studies demonstrated that HSV-TK-expressing cells and bystander cells could be separated by this technique with greater than 98% purity in each population (data not shown). 
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illustrates that GCVTP accumulated in bystander cells separated after coculture with HSV-TK-expressing cells and 100 mM GCV. Although these levels were low (213784 pmol/10 6 cells) after 24 h of incubation with 100 mM GCV, they were significantly higher than the levels of GCVTP that accumulated in cultures of 100% non-HSV-TK-expressing HeLa cells incubated similarly (1.570.4 pmol/10 6 cells, data not shown). At each time point, there was substantially less GCVTP in the bystander cells compared to the HSV-TK-expressing cells. These studies also demonstrated that the HSV-TK-expressing cells from this coculture accumulated less than half as much GCVTP as cultures with 100% HSV-TK-expressing cells after 24 h (867733 versus 17737188 pmol/10 6 cells, respectively). This suggests that the transfer of GCV phosphates from HSV-TKexpressing to bystander cells decreased the cytotoxicity to the HSV-TK-expressing cells.
GCVTP retention in HSV-TK and bystander cells
The level of GCVTP that accumulated in the bystander cells shown in Figure 6 would be predicted to cause cytotoxicity, since similar levels accumulated in cultures of 100% HSV-TK-expressing cells incubated with 10 mM GCV for 24 h and produced 499% cell kill (data not shown). We hypothesized that a more rapid degradation of GCVTP in the post-GCV exposure period in bystander compared to HSV-TK-expressing cells would lessen toxicity to the bystander cells. As illustrated in Figure  7 , the half-life for GCVTP in the HSV-TK-expressing cells (7.0 h) and bystander cells (6.1 h) from the 50:50 coculture was approximately half that of the 100% HSV-TK-expressing cell culture (12.3 h). The decreased half-life of GCVTP in the HSV-TK-expressing cells from (Figure 8 ). The data suggest that the lack of bystander cytotoxicity was the result of low levels of GCVTP and decreased half-life in bystander cells compared to that of HSV-TK-expressing cells.
Discussion
Bystander cell killing from HSV-TK/GCV suicide gene therapy has been attributed to the ability to transfer GCV phosphates from HSV-TK-expressing to the HSV-TKnonexpressing cells via GJIC. 8, 29, [37] [38] [39] Consistent with this premise, we and others have demonstrated that cells with high GJIC exhibit good bystander cytotoxicity. 26, 29, 31 In contrast, HeLa and other cell lines that reportedly lack GJIC do not exhibit bystander killing with HSV-TK/ GCV. 30, 33 In an attempt to explore further the relationship between bystander cytotoxicity and GJIC, we utilized two cell lines that lacked GJIC according to Lucifer Yellow microinjection: (1) U251 cells transfected with a DNCx43 cDNA, 45 and (2) HeLa cells, which are thought to be devoid of GJIC due to lack of expression of connexin proteins. 33 The data demonstrated that both cell lines were capable of accepting GCV phosphates from neighboring HSV-TK cells. In each case, the drug metabolite transfer was mediated by GJIC, as both cell types were capable of transferring calcein in a double dye flow cytometry technique, although they did not show detectable transfer of Lucifer Yellow. Furthermore, transfer of GCV phosphates from HeLa HSV-TK-expressing to HSV-TK-nonexpressing cells did not result in bystander cytotoxicity, due to rapid degradation of GCVTP in the bystander population.
The results presented here demonstrated important differences in GJIC measured by Lucifer Yellow microinjection compared to the double dye flow cytometry technique. While both the DN14 cells and HeLa cells exhibited 0% GJIC by Lucifer Yellow, the flow cytometry technique demonstrated transfer of calcein to 29 and 23% of the cells, respectively. Both methods are thought to represent dye transfer through gap junctions. The variation in results between the two methods may be due to several factors. First, Lucifer Yellow microinjection relies on visual detection under a microscope of dye transfer, 47 whereas the double dye technique utilizes the more sensitive detection of fluorescence by flow cytometry. 46, 48 Indeed, the flow diagrams indicated that there was measurable but low transfer of calcein in both cell types. Second, it is possible that the accumulation of detectable levels of dye through gap junctions is slow, such that GJIC was apparent during the 24-h period of detection by flow cytometry, but not in the 10 min observation period following Lucifer Yellow microinjection. Consistent with this interpretation, we observed faint transfer of calcein in the DN14 cells after microinjection (data not shown).
These results demonstrate that, although expression of the DNCx43 construct greatly reduced GJIC in the U251 cells, it did not eliminate communication. Certainly, it is possible that there was enough expression of the DNCx43 to be incorporated into some, but not all, gap junction channels. This reduction in GJIC may have 30, 33 It has been suggested that the Cx43 promoter is hypermethylated in HeLa cells, accounting for variable expression depending upon promoter methylation status. 49 Furthermore, the transfer of negatively charged GCV phosphates in both cell lines also supports the hypothesis that these cell lines have GJIC.
The presence of GJIC is consistent with the bystander cytotoxicity observed in the DNCx43 U251 cell lines. It is interesting to note that the bystander cytotoxicity was similar in all clones, despite their differences in GJIC measured by Lucifer Yellow. It is possible that the gap junctions in the cell lines transfer GCV phosphates similarly but differ with respect to Lucifer Yellow dye transfer. As suggested above, Lucifer Yellow transfer over a period of minutes may not accurately reflect the ability of the cells to transfer GCV phosphates over a 24-h period. The DN7 and DN10 clonal cell lines exhibited GJIC as measured by double dye flow cytometry similar to that of the empty vector control over a 24-h period (77.4 and 79.8, respectively). However, the intensity of calcein fluorescence for the DN7 and DN10 clones was approximately half that of the empty vector control, indicating that the flow of dye from one cell to another was inhibited. If the flow of phosphorylated GCV is inhibited in a similar manner, it is possible that the reduced rate of transfer provided insufficient concentrations of GCV for the DNCx43 cell lines to exhibit bystander cytotoxicity similar to that of the empty vector control. Alternatively, the high sensitivity of the U251 cells to GCVTP may lessen the effect of small differences in GCV phosphate transfer.
In the HeLa cells, GJIC appeared to mediate transfer of GCV phosphates, but that did not result in significant bystander cytotoxicity. These results demonstrated that levels of GCVTP in the bystander cells were consistently lower than in the HSV-TK-expressing cells, consistent with previous reports from our lab in other cell lines. 8, 29 The presence of bystander cells can decrease the amount of GCVTP in HSV-TK-expressing cells as reported previously by us and others. 8, 29, 50 In HeLa cells, this appears to be explained by both the transfer of GCVTP and its rapid half-life in the bystander compared to the HSV-TK-expressing cells. These results suggest that the presence of HSV-TK contributes to a longer half-life for GCVTP by allowing reutilization of GCV after dephosphorylation of GCV phosphates. Our results are consistent with those of others who have reported a lack of bystander killing with HSV-TK/GCV in HeLa cells. [30] [31] [32] [33] However, here we have demonstrated that this is not due to a lack of GJIC, as suggested previously, but rather the accelerated half-life of GCVTP in bystander cells.
The rapid degradation of GCVTP in cells lacking HSV-TK has important implications for the clinical translation of the HSV-TK/GCV strategy. As current technologies only allow gene transfer to a relatively low percentage of tumor cells in vivo, bystander cell killing is a crucial component for the HSV-TK/GCV approach. Based on the premise that GJIC is the major route for transfer of GCV phosphates to bystander cells, investigators have proposed enhancement of GJIC in tumors through transfection of a cDNA coding for a connexin protein. However, the results presented here indicate that, depending upon the cell type, improving GJIC in tumors may decrease toxicity to the HSV-TK-expressing cells, while not increasing bystander cell killing. Thus, other approaches to improve bystander cell killing are warranted. We have previously demonstrated that introduction of a mechanistically based inhibitor designed to decrease the endogenous competitor (dGTP) for GCVTP incorporation into DNA synergistically enhanced bystander cytotoxicity in several different tumor cell lines. 11, 44 This strategy was successful both in vitro and in vivo. This approach may form an important addition to clinical trials.
Materials and methods
Cell culture and generation of stable cell lines
The U251 glioblastoma and HeLa cell lines were cultured in RPMI 1640 medium supplemented with 2 mM Lglutamine and 10% calf serum (Gibco BRL, Grand Island, NY, USA). Exponentially growing cells were maintained in a humidified 371C incubator with an atmosphere containing 5% CO 2 and 95% air.
Generation of U251 and HeLa cell lines that stably express the HSV-TK or b-gal was accomplished through transduction with a retrovirus vector containing the corresponding cDNA as described previously.
9 U251 cells were transfected with pCRt2 containing the cDNA for the DNCx43 protein and the cDNA for neomycin resistance. Transgene-expressing cells were selected with 400 mg/ml G418. DNCx43 expression was verified by Northern and Western blot analysis. 47 
Cell survival assay
Cytotoxicity in U251 and HeLa exponentially growing cells was measured in cultures that contained HSV-TKexpressing and/or b-gal cells or DNCx43 expressing clones treated with 0.01 to 1000 mM GCV (Cytovene, Syntex, Palo Alto, CA, USA) for 24 h. After drug incubation, cells were harvested by trypsinization, enumerated using a Coulter electronic particle counter (Hialeah, FL, USA), and plated in six-well dishes at an approximate 100 viable cells per well. After 7-12 days, bystander cell survival was determined by fixing colonies in 1% gluteraldehyde, staining with 0.2% X-gal, and enumerating blue colonies. After bystander cell survival was determined, plates were stained with 4% crystal violet to determine survival of all colonies. The difference between the total number of colonies and the number of bystander colonies gives the survival of HSV-TK-expressing cells. Cell survival was calculated as a fraction of the plating efficiency for untreated control cells for each cell type. All colony formation assays were performed independently at least three times and each condition was plated in triplicate.
Lucifer Yellow microinjection to measure GJIC Levels of GJIC in cultures of U251 glioblastoma and HeLa cells were determined by microinjection of Lucifer Yellow tracer dye and quantification of the spread of dye to adjacent cells as described previously. 47 Frequency of dye transfer was determined visually. GJIC was measured as the percentage of directly adjacent cells that received dye from the microinjected central cell. At least GCV phosphate transfer in HeLa cells BG Gentry et al 10 cells per dish were microinjected with three total dishes tested per condition.
Northern blot analysis
Northern blot analysis of Cx43 mRNA levels in U251 cells was performed as described previously. 47 Briefly, a random primer-labeled [ 32 P]Cx43 cDNA was allowed to hybridize to the blots (15 mg total RNA per lane) overnight. The membranes were washed and exposed to Kodak XAR-5 X-ray film with an intensifying screen for 24 h at À801C, and then developed in an automatic X-ray film developer. The cDNA for the DNCx43 was cloned into the pCR3 expression vector, which contains the bovine growth hormone polyA signal, and therefore results in a shorter mRNA when compared to wild-type Cx43.
Western blot analysis
Levels of phosphorylated and nonphosphorylated Cx43 in U251 glioblastoma cells were analyzed as described previously. 47 Briefly, cells transfected with the DNCx43 gene were harvested by scraping, sonicated, and centrifuged to pellet the membranes. Pellets were dissolved and protein levels were determined using the DC Protein Assay (BioRad Corp., Richmond, CA, USA). In all, 15 mg of protein per sample was electrophoresed under reducing conditions and blotted electrophoretically to Immobilon-P membranes (Millipore Corp., Bedford, MA, USA). Detection of Cx43 was performed using a mouse monoclonal antibody and a biotin-streptavidin alkaline phosphate detection kit (Amersham Corp.).
Double dye flow cytometry to measure GJIC
For calcein labeling, cells grown to approximately 75% confluency were washed and then stained for 1 h with 20 mM calcein-AM 51 (Molecular Probes Inc.) dissolved in OptiMem serum-free media containing 0.04% DMSO and 0.04% Pluronic-F127 (Molecular Probes Inc.). After labeling, the cells were washed and incubated in RPMI 1640 containing 10% calf serum. For PKH26 labeling, cells were harvested, washed with OptiMem serum-free media, resuspended in Diluent C to a concentration of 10 7 cells/ml, and stained with 20 mM PKH26 dissolved in Diluent C (Sigma, St Louis, MO, USA). 52 After 5 min of staining, cells were washed multiple times with RPMI 1640 containing 10% calf serum.
At 24 h after calcein-and PKH26 staining, cells were harvested by trypsinization, counted using a Coulter electronic particle counter, and equal numbers of calceinand PKH26-labeled cells were plated to confluency in a 24-well dish. After designated time periods, cells were trypsinized, washed, resuspended in 0.5 ml PBS, and analyzed by flow cytometry. Samples were gated to eliminate cell fragments and those undergoing apoptosis and/or necrosis. Calcein fluorescence was detected at an emission max of 514 nm and PKH26 was detected at an emission max of 567 nm. 46 
Fluorescence-activated cell sorting
HeLa bystander (b-gal) cells were harvested, washed with OptiMem serum-free media, resuspended in Diluent C to a concentration of 10 7 cells/ml, and stained with 20 mM PKH26 dissolved in Diluent C (Sigma, St Louis, MO, USA). 52 After 5 min of staining, cells were washed multiple times with RPMI 1640 containing 10% calf serum. Immediately after staining, the PKH26-labeled bystander cells were plated with equal numbers of HSV-TK-expressing HeLa cells to approximately 50% confluency. After 24 h, cultures were incubated with 100 mM GCV for designated times. After incubation with drug, the cells were removed, washed with PBS, and resuspended at a concentration of 4.0 Â 10 6 cells/ml. Samples were analyzed using a flow cytometer, which separated the two populations based on PKH26 fluorescence at 567 nm. Purity of the samples was checked using the flow cytometer and by plating a portion of each sample followed by staining with X-gal.
Analysis of GCV phosphorylated metabolites
After incubation with GCV for designated time points, cells were harvested and nucleotides were extracted with perchloric acid and neutralized with potassium hydroxide. GCVTP was separated from endogenous nucleotides and quantitated by strong anion exchange HPLC as described previously. 9 Nucleotides were quantitated by comparison of their peak areas with that of known amounts of the appropriate standard at wavelengths 254 and 281 nm.
